https://www.selleckchem.com/pr....oducts/lirafugratini
B-cell depletion induced by anti-cluster of differentiation 20 (CD2 monoclonal antibody (mAb) therapy of patients with lymphoma is expected to impair humoral responses to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination, but effects on CD8 T-cell responses are unknown. Here, we investigated humoral and CD8 T-cell responses following two vaccinations in patients with lymphoma undergoing anti-CD20-mAb therapy as single agent or in combination with chemotherapy or other anti-neoplastic agents during the las
Curtir
Comentario
Compartilhar
